The breast health of women of all ages is a major health concern, and early detection and diagnosis from a breast cancer screening machine ensure the prevention of the disease.

On World Health Day, celebrated annually on the 7th of April, we kicked off with an activity nationwide women’s breast health campaign for the entire month. The aim is to raise awareness about routine breast screening, the importance of early breast cancer detection and diagnosis, and prevention of the disease to lower breast cancer incidence, alongside highlighting the ‘Koning Vera 3D Breast CT Scanner‘.

Breast cancer impacts millions of women in the UK and a combination of factors may influence it. The main risk factors are gender and age, primarily affecting women aged 50 and older. While some women may develop breast cancer without identifiable risk factors, having these factors doesn’t mean the disease will occur and not all risk factors do have an equal effect.

Most women have common symptoms, but less risk of breast cancer. Talk to your local GP if any symptoms may occur, and ways you can reduce your risk of developing breast cancer and about routine breast cancer screening.

Senior research leads Professor Carlo La Vecchia (MD) from Medical Statistics and Epidemiology at the University of Milan (Italy), has suspected, that the higher in breast cancer deaths among elderly EU women may be due to unaware/lower screening rates and less access to advanced treatments in the 80+ age group.

He arguably said: “Elderly women aren’t invited to routine breast screening and faced poor adjuvant breast cancer management”.

The higher percentage of overweight and obese people over the past few decades in most affected countries in Central and Northern Europe has led to a higher risk of developing breast cancer.

To date, this hasn’t been offset by better diagnosis and management among the elderly and this is the major reason for the greater number of deaths in the 80+ and above age group.

Develop a future where to lower women’s risk of developing breast cancer!

Despite ongoing offset, invasive breast cancer risks remain one of the most prevalent/common cancers among women. However, adjuvant breast cancer management and routine breast cancer screening above the 50+ age group (women) can help break this higher trend and close the risk of developing breast cancer incidence.

Throughout this month of April, Euronoxx Medical Group will run various campaigns and initiatives to support breast cancer screening from full field digital mammography system – ‘Koning Vera breast CT Scanner technology’ — encourage NHS, hospitals, clinics across the UK, groups ranging from breast cancer advocacy organizations, NGOs to local community organizations greatly associated with major healthcare supports and invite national health regulatory bodies to know the latest FDA-approved 3D imaging breast cancer screening technology. This clinical breast screening test helps early detection of any breast lesions and catches them before become palpable.

The growing trends of these Breast cancer statistics 2025, are growing. But routine breast screening for early detection and early diagnosis is way can change this.

Think about how great it would be for more women to not have to hear a breast cancer diagnosis within their lifetime! Together, we can act against breast cancer and save lives through prevention.

It would be great for women if not to hear about a breast cancer diagnosis in their lifetime. Routine breast screening to help identify at an early stage is a bold act against near-zero breast cancer incidence and only way to save breast cancer mortality rates is through screening tests from Koning Vera Breast CT Scanner 3D isotopic imaging technology.

It — aimed at:

• Supporting UK healthcare infrastructure to get latest breast cancer screening technology to breast cancer-affected people, including patients with metastatic breast cancer.
• Supply of FDA-approved breast cancer screening machine across all healthcare facilities
• Encourage women to get access to routine breast cancer screening at the age of 50 or earlier, including a family history of breast cancer risk.
• Women health & charities, NHS, to access this technology who offer breast cancer screenings.

Did you know that approximately 56,000 women in the UK receive a breast cancer diagnosis annually?

That’s over 150 cases each day, showing the significant impact of this disease. In consideration of this fact, we may say, if this trend continues, 1 in 7 women in the UK will face a breast cancer diagnosis in their lifetime, so this highlights the importance of breast cancer awareness and use of breast screening technology for breast cancer prevention efforts.

World Health Day 2025 is a call on everyone for routine breast screening for early stage breast cancer detection – to all women (including suspect breast cancer symptoms), healthcare providers, friends, and advocates – to participate in the campaign “Stop Sufferings, Healthy Beginnings”.

The innovative ‘Koning Vera 3D full field digital mammography system’ plays a gold standard routine breast screening procedure and helps your healthcare practitioner to easily identify any breast lumps less than 2mm in size or view dense breast tissue. This full field digital mammography system helps in early detection of the smallest breast cancer lesions through its advanced 3D near-isotropic resolution imaging capabilities and generates exceptional spatial resolution images in less than 7 seconds of each breast.